Clinical trial
Blood Test for Ovarian Cancer Associated Antibodies (CAAb)
NCT00327925 · Lab Discoveries Ltd., Industry · Unknown status
Key facts
| NCT number | NCT00327925 |
|---|---|
| Title | Blood Test for Ovarian Cancer Associated Antibodies (CAAb) |
| Official title | Study to Assess the Effectiveness of the CAAb Test With Ovarian Cancer Patients |
| Lead sponsor | Lab Discoveries Ltd., Industry |
| Status | Unknown status |
| Study type | Observational |
| Conditions | Ovarian Cancer |
| Intervention type | Procedure |
| Interventions | Find Cancer Associated Antibodies |
| Enrollment | 60 |
| Start date | Jul 1, 2006 |
| Completion | Jun 1, 2008 |
| First posted | May 19, 2006 |
| Last update posted | Mar 2, 2007 |
| Countries | Israel |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: